Evidence map›Paper›PMID 36140078›Full record

ArticleBiosensors2022

Apoptosis Detection in Retinal Ganglion Cells Using Quantitative Changes in Multichannel Fluorescence Colocalization.

Xudong Qiu, Seth T Gammon, James R Johnson, Federica Pisaneschi, Steven W Millward, Edward M Barnett, David Piwnica-Worms

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xudong QiuDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Seth T GammonDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-8647-0975
James R JohnsonMallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO 63130, USA.
Federica PisaneschiDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-1989-4417
Steven W MillwardDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Edward M BarnettDepartment of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
David Piwnica-WormsDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-2120-7217
The University of Texas MD Anderson Cancer Center · USMedical College of Wisconsin · USWashington University in St. Louis · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
MEMBRANE PERMEANT PEPTIDES FOR IMAGING CELL FUNCTIONR01EY019587 · NEI · WASHINGTON UNIVERSITY · PI PIWNICA-WORMS, DAVID · 2009 to 2022
$5.3M
NEI NIH HHS R01 EY019587NIH HHS P30 CA016672NIH HHS R01 EY019587
6 · The paper itself

Abstract

KcapTR488 is a dual-fluorophore peptide sensor for the real-time reporting of programmed cell death by fluorescence imaging. KcapTR488 contains a nuclear localization sequence (NLS) conjugated with Texas Red, a caspase-cleavable sequence (DEVD), and a C-terminus conjugated to Alexa Fluor 488 (AF488). The synthesis and preliminary evaluation in cellulo of KcapTR488 for monitoring cell death by fluorescence imaging has been previously reported, but its utility in vivo has yet to be tested or validated. Herein, in vitro solution experiments verified the intramolecular fluorescence resonance energy transfer (FRET) between the two fluorophores and enabled a quantitative analysis of enzyme rates and selectivity. The sensor delivery kinetics in live rat models were quantified by ex vivo fluorescence microscopy. Studies in healthy control retinas demonstrated that KcapTR488 concentrated in the nucleus of retinal ganglion cells (RGC), with a strong colocalization of red and green fluorescence signals producing robust FRET signals, indicating an intact reporter. By contrast, using an acute but mild NMDA-induced retinal injury model, dual-color confocal ex vivo microscopy of cleaved KcapTR488 identified sensor activation as early as 2 h after injection. Quantitative changes in fluorescence colocalization were superior to changes in FRET for monitoring injury progression. Longitudinal monitoring revealed that the NLS-Texas Red fragment of the cleaved sensor moved out of the cell body, down the axon, and exited the retina, consistent with anterograde axonal transport. Thus, KcapTR488 may be a powerful tool to study RGC death pathways in live preclinical models of glaucoma.

Indexed as

N-MethylaspartateRetinal Ganglion CellsAnimalsApoptosisCaspasesFluoresceinsFluorescent DyesPeptidesRatsSulfonic Acidsalexa fluor 488CaspasesFluoresceinsFluorescent DyesN-MethylaspartatePeptidesSulfonic Acidsanterograde axonal transportapoptosisdual-fluorophore peptide sensorfluorescence colocalizationfluorescence resonance energy transferglaucomamultispectral detectionNMDAretinal ganglion cell

Identifiers

PMID36140078
PMCPMC9496076
OpenAlexW4293414206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.